esc semaglutide 2025: Novo Nordisk's Wegovy superior to Zepbound in reducing CV events 1 / Insulin Pen Case Lemonelle Ozempic, Wegovy: Women with heart

This is about the same price as 4, 0.75 mL of 2.4 mg/0.75 mL pens of Wegovy, but around $300 more expensive than 4, 0.5 mL of 5 mg/0.5 mL pens of Zepbound (tirzepatide)

Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): A 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial

When in doubt, seek clinical advice before administering the injection

The impact of glucose control on macrovascular complications is less certain but is supported by multiple meta-analyses and epidemiological studies

Pediatric Research, 99(2), 502510